Basics Adaptive Biotechnologies Corporation IPO Date: June 24, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.44B Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 3.35% Avg Daily Range (30 D): $0.29 | 3.59% Avg Daily Range (90 D): $0.27 | 3.57% Institutional Daily Volume Avg Daily Volume: 1.03M Avg Daily Volume (30 D): 2.32M Avg Daily Volume (90 D): 1.81M Trade Size Avg Trade Size (Sh.): 94 Avg Trade Size (Sh.) (30 D): 88 Avg Trade Size (Sh.) (90 D): 89 Institutional Trades Total Inst.Trades: 2,552 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $1.82M Avg Inst. Trade (90 D): $1.59M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.26M Avg Closing Trade (30 D): $2.35M Avg Closing Trade (90 D): $1.91M Avg Closing Volume: 132.4K         News Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Dec 7, 2024 @ 11:30 PM Adaptive Biotechnologies Announces New Data at the... Source: Adaptive Biotechnologies Corporation Aug 15, 2024 @ 2:58 PM Laboratory-Developed Tests (LDTs) World Market For... Source: Researchandmarkets.Com Aug 13, 2024 @ 8:58 AM Hematologic Malignancies Testing Markets, 2023-203... Source: Researchandmarkets.Com Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.2 $-.22 Diluted EPS $-.2 $-.22 Revenue $ $ 52.44M $ 46.44M Gross Profit $ $ 35.46M $ 29.77M Net Income / Loss $ $ -29.83M $ -32.1M Operating Income / Loss $ $ -29.6M $ -32.63M Cost of Revenue $ $ 16.98M $ 16.67M Net Cash Flow $ $ 2.54M $ -21.74M PE Ratio